Columbia University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1754-01-01

Employees: 20.8K

Market Cap: -

Website: https://www.arch.columbia.edu

Clinical Trials

SUNLIGHT Study: Online Support Groups for MS to Address COVID-19

Not Applicable

Completed

Conditions: COVID-19
MS (Multiple Sclerosis)
Support Groups

Interventions: Behavioral: Online support Group

First Posted Date: 2020-05-07

Last Posted Date: 2021-01-08

Lead Sponsor: Columbia University

Target Recruit Count: 32

Registration Number: NCT04379661

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs)

Phase 2

Active, not recruiting

Conditions: Immune-related Adverse Events
Advanced Solid Tumor

Interventions: Drug: Tocilizumab
Drug: Rituximab

First Posted Date: 2020-05-05

Last Posted Date: 2025-05-12

Lead Sponsor: Columbia University

Target Recruit Count: 8

Registration Number: NCT04375228

Locations: 🇺🇸
Johns Hopkins, Baltimore, Maryland, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center, New York, New York, United States

Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19

Phase 4

Completed

Conditions: COVID-19
Venous Thromboses
Arterial Thrombosis

Interventions: Drug: Heparin Infusion
Drug: Enoxaparin Prophylactic Dose
Drug: Heparin SC
Drug: Enoxaparin/Lovenox Intermediate Dose

First Posted Date: 2020-04-29

Last Posted Date: 2024-12-10

Lead Sponsor: Columbia University

Target Recruit Count: 94

Registration Number: NCT04367831

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers

Recruiting

Conditions: Coronavirus
Covid-19
Coronavirus Infection

Interventions: Other: COVID-19 Serology
Behavioral: Health Care Worker Survey

First Posted Date: 2020-04-29

Last Posted Date: 2025-04-04

Lead Sponsor: Columbia University

Target Recruit Count: 1000

Registration Number: NCT04367857

Locations: 🇺🇸
NewYork-Presbyterian Hosptial/Columbia University Irving Medical Center, New York, New York, United States

Sildenafil for Treatment of Choroidal Ischemia

Phase 2

Active, not recruiting

Conditions: Vitelliform Macular Dystrophy
Age-related Macular Degeneration
Retinitis Pigmentosa
Central Serous Retinopathy
Choroidal Ischemia

Interventions: Other: Standard of Care Sildenafil
Drug: Sildenafil
Diagnostic Test: Ocular Coherence Tomography-Angiography (OCT-A)
Other: Visual Acuity (VA)

First Posted Date: 2020-04-22

Last Posted Date: 2023-10-23

Lead Sponsor: Columbia University

Target Recruit Count: 25

Registration Number: NCT04356716

Locations: 🇺🇸
Columbia University Medical Center, Edward Harkness Eye Institute, New York, New York, United States

Cerebrospinal Fluid Biomarkers in Bariatric Surgery

Not Applicable

Recruiting

Conditions: Obesity

Interventions: Procedure: Roux-en-Y Gastric Bypass (RYGB)
Procedure: Sleeve Gastrectomy (SG)
Behavioral: Very Low Calorie Diet (VLCD)

First Posted Date: 2020-04-17

Last Posted Date: 2025-02-04

Lead Sponsor: Columbia University

Target Recruit Count: 48

Registration Number: NCT04350892

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Saved From COVID-19 - Chloroquine (CQ) Prophylaxis for Health Care Workers at Risk for COVID

Phase 2

Terminated

Conditions: Coronavirus Infection
COVID

Interventions: Drug: Placebo oral tablet
Drug: Chloroquine

First Posted Date: 2020-04-16

Last Posted Date: 2025-02-27

Lead Sponsor: Columbia University

Target Recruit Count: 5

Registration Number: NCT04349371

Locations: 🇺🇸
Columbia University Irving Medical Center/NYP, New York, New York, United States

Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19

Phase 2

Terminated

Conditions: Solid Tumor
Sars-CoV2
Hematological Malignancy

Interventions: Drug: BMS-986253

First Posted Date: 2020-04-15

Last Posted Date: 2025-05-22

Lead Sponsor: Columbia University

Target Recruit Count: 43

Registration Number: NCT04347226

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

Volunteering Program for Chinese Dementia Caregivers

Not Applicable

Completed

Conditions: Caregiver Burnout

Interventions: Behavioral: Peer Mentoring Program

First Posted Date: 2020-04-15

Last Posted Date: 2023-02-10

Lead Sponsor: Columbia University

Target Recruit Count: 46

Registration Number: NCT04346745

Locations: 🇺🇸
Columbia University, New York, New York, United States

Acquiring Convalescent Specimens for COVID-19 Antibodies

Completed

Conditions: Coronavirus Infection
Corona Virus Infection
COVID-19

First Posted Date: 2020-04-10

Last Posted Date: 2022-07-20

Lead Sponsor: Columbia University

Target Recruit Count: 15

Registration Number: NCT04342195

Locations: 🇺🇸
Columbia University Irving Medical Center/NYP, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy